Prothena Plc Company Insiders

PRTA Stock  USD 21.16  0.59  2.87%   
Prothena Plc's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Prothena plc suggests that vertually all insiders are panicking. Prothena Plc employs about 173 people. The company is managed by 28 executives with a total tenure of roughly 157 years, averaging almost 5.0 years of service per executive, having 6.18 employees per reported executive.
Dale Schenk  CEO
CEO and President and Director
Lars Ekman  Chairman
Independent Chairman of the Board

Prothena Plc's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-01-24Karin L. WalkerDisposed 5000 @ 34View
2023-12-20Karin L. WalkerDisposed 5000 @ 37.19View
2023-11-30Karin L. WalkerDisposed 5000 @ 34View
2023-10-25Karin L. WalkerDisposed 5000 @ 41.04View
2023-10-11Brandon S. SmithDisposed 4000 @ 46.75View
2023-10-04Carol D. KarpDisposed 5000 @ 46.62View
2023-09-27Michael J. MalecekDisposed 5000 @ 47.38View
2023-09-19Karin L. WalkerDisposed 5000 @ 52.36View
2023-09-13Hideki GarrenDisposed 2000 @ 55.48View
2023-09-06Carol D. KarpDisposed 5000 @ 54.76View
2023-08-30Michael J. MalecekDisposed 5000 @ 55.01View
2023-08-18Karin L. WalkerDisposed 5000 @ 57.18View
2023-08-16Hideki GarrenDisposed 2000 @ 58.74View
2023-08-02Wagner M. ZagoDisposed 4000 @ 67.05View
2023-07-26Michael J. MalecekDisposed 5000 @ 62.33View
2023-07-19Karin L. WalkerDisposed 5000 @ 69.19View
2023-07-12Hideki GarrenDisposed 2000 @ 67.51View
Monitoring Prothena Plc's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Prothena Plc's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Prothena Plc's future performance. Based on our forecasts, it is anticipated that Prothena will maintain a workforce of about 170 employees by May 2024.
 
Yuan Drop
 
Covid

Prothena Plc Management Team Effectiveness

The company has return on total asset (ROA) of (0.1642) % which means that it has lost $0.1642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2485) %, meaning that it created substantial loss on money invested by shareholders. Prothena Plc's management efficiency ratios could be used to measure how well Prothena Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to -0.21. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Prothena Plc's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 42.3 M, whereas Total Assets are forecasted to decline to about 414.8 M.
As of April 19, 2024, Common Stock Shares Outstanding is expected to decline to about 35.1 M. In addition to that, Net Loss is expected to decline to about (110.5 M)

Prothena Plc Workforce Comparison

Prothena plc is rated below average in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 2,957. Prothena Plc holds roughly 173 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (248.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $248.47.

Prothena Plc Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prothena Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prothena Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Prothena Plc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
5.0
10
2
 1,008,000 
 10,000 
2023-12-01
0.3333
5
15
 24,000 
 48,000 
2023-09-01
0.3333
18
54
 76,000 
 152,000 
2023-06-01
0.4407
26
59
 376,333 
 482,666 
2023-03-01
0.5294
18
34
 588,834 
 215,668 
2022-12-01
0.2564
20
78
 239,500 
 454,280 
2022-09-01
0.3889
14
36
 194,662 
 399,246 
2022-06-01
1.5
15
10
 1,252,736 
 1,092,736 
2022-03-01
4.0
12
3
 1,165,500 
 5,000 
2021-12-01
0.2667
8
30
 72,519 
 145,038 
2021-09-01
0.3824
13
34
 146,676 
 99,646 
2021-06-01
1.5
15
10
 774,250 
 245,000 
2021-03-01
1.4146
58
41
 3,310,222 
 1,434,200 
2020-09-01
1.0
1
1
 10,000 
 10,000 
2018-12-01
0.5
1
2
 35,000 
 130,000 
2017-12-01
0.3333
1
3
 3,500 
 7,000 
2017-09-01
0.4348
10
23
 54,600 
 109,200 
2017-06-01
0.8462
11
13
 200,500 
 123,000 
2017-03-01
0.8235
14
17
 374,709 
 97,418 
2016-12-01
0.5294
9
17
 172,292 
 84,584 
2016-09-01
0.4615
6
13
 79,500 
 59,000 
2016-06-01
1.0
12
12
 104,000 
 27,820 
2016-03-01
1.1
11
10
 592,125 
 14,250 
2015-12-01
0.3143
11
35
 182,916 
 359,166 
2015-09-01
0.3235
11
34
 109,916 
 209,833 
2015-06-01
1.1429
8
7
 120,125 
 30,250 
2015-03-01
1.6667
10
6
 443,625 
 37,250 
2014-12-01
0.5
3
6
 7,500 
 15,000 
2014-09-01
1.0
2
2
 4,500 
 5,000 
2014-06-01
4.0
8
2
 147,356 
 16,000 
2014-03-01
7.0
7
1
 402,000 
 3,182,253 
2013-09-01
1.0
1
1
 50,000 
 0.00 

Prothena Plc Notable Stakeholders

A Prothena Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Prothena Plc often face trade-offs trying to please all of them. Prothena Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Prothena Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dale SchenkCEO and President and DirectorProfile
Lars EkmanIndependent Chairman of the BoardProfile
Tran NguyenCFOProfile
Christopher HenneyIndependent DirectorProfile
Paula CobbDirectorProfile
Shane CookeIndependent DirectorProfile
Richard CollierIndependent DirectorProfile
Dennis SelkoeIndependent DirectorProfile
Anders HarfstrandDirectorProfile
Hideki MDChief OfficerProfile
Sarah NoonbergChief Medical OfficerProfile
Tara NickersonChief Business Officer and SecretaryProfile
Jennifer ZibudaDirector CommunicationProfile
Brandon SmithChief OfficerProfile
Carol KarpChief Regulatory OfficerProfile
David FordChief OfficerProfile
Yvonne TchrakianCompany SecProfile
Karin CPAChief ControllerProfile
Gene KinneyChief Scientific Officer and Head of RandDProfile
CPA CPAChief ControllerProfile
David McNinchChief Commercial OfficerProfile
Arthur HomanChief Legal OfficerProfile
Martin KollerChief Medical OfficerProfile
Wagner ZagoChief Scientific OfficerProfile
Karin WalkerChief Accounting Officer and ControllerProfile
Michael MalecekChief SecretaryProfile
Mark CFAVice RelationsProfile
Tran MBACFO OfficerProfile

About Prothena Plc Management Performance

The success or failure of an entity such as Prothena plc often depends on how effective the management is. Prothena Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Prothena management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Prothena management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.20)(0.21)
Return On Capital Employed(0.30)(0.28)
Return On Assets(0.21)(0.22)
Return On Equity(0.26)(0.25)
The data published in Prothena Plc's official financial statements usually reflect Prothena Plc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Prothena plc. For example, before you start analyzing numbers published by Prothena accountants, it's critical to develop an understanding of what Prothena Plc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Prothena Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Prothena Plc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Prothena plc. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.

Prothena Plc Workforce Analysis

Traditionally, organizations such as Prothena Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Prothena Plc within its industry.

Prothena Plc Manpower Efficiency

Return on Prothena Plc Manpower

Revenue Per Employee528.2K
Revenue Per Executive3.3M
Net Loss Per Employee849.9K
Net Loss Per Executive5.3M
Working Capital Per Employee3.4M
Working Capital Per Executive20.8M
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Prothena Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.76)
Revenue Per Share
1.717
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.25)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.